Bio Impact Capital LLC Ptc Therapeutics, Inc. Transaction History
Bio Impact Capital LLC
- $669 Million
- Q4 2024
A detailed history of Bio Impact Capital LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 434,767 shares of PTCT stock, worth $22 Million. This represents 2.93% of its overall portfolio holdings.
Number of Shares
434,767
Previous 89,715
384.61%
Holding current value
$22 Million
Previous $3.33 Million
489.69%
% of portfolio
2.93%
Previous 0.52%
Shares
2 transactions
Others Institutions Holding PTCT
# of Institutions
257Shares Held
77.3MCall Options Held
179KPut Options Held
536K-
Vanguard Group Inc Valley Forge, PA9.18MShares$465 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$394 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$375 Million5.44% of portfolio
-
Armistice Capital, LLC New York, NY6.38MShares$323 Million4.07% of portfolio
-
Wellington Management Group LLP Boston, MA4.79MShares$243 Million0.04% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.63B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...